InferVision
Infervision is an AI high-tech company that uses deep learning technology and computer vision to help diagnose cancers.
InferVision, founded in January, 2016 and headquartered in Beijing, is an artificial intelligence medical system service provider. Established by Chen Kuan and Xia Chen, the company has received financings from CDH, Sequoia China, Haitong Kaiyuan and so on. Rivals that have direct and indirect competition with InferVision globally include AIdoc Medical, MedXT, Jianpei Technology, etc.
F-star to be acquired by China biopharmaceutical with USD 161million
"Delisting warning" of Whitson pharmaceuticals on the New York Stock Exchange
East China medicine "liraglutide" goes to sea
Research
Consumer Staples, Healthcare, TechnologyWIA2020 | Rising Tech Stars 2020: Global & China's 100
Nearly half of the equity of two subsidiaries of Tongrentang was transferred to Tongrentang medical care
Baiyunshan: suspension of the spin off of Guangzhou Pharmaceutical for overseas listing
Germany Merck "cetuximab" new indications for head and neck squamous cell carcinoma approved in China
Yanye new crown drug 3CL protein inhibitor has been suspended approval
Open Source, Open Mind: Baidu and LinkingMed Help Doctors in Medical Images
A Chinese startup, based on Baidu’s deep-learning open-source platform PaddlePaddle, is providing CT screening service to a Hunan-based hospital, hoping to facilitate the diagnosis process.
Mar 05, 2020 11:41 AM
Sanofi Greater China will be headed by Shi Wang, and Henting he will become the global head of the digital business unit
Acadia Alzheimer's drug SNDA application rejected by FDA advisory committee
Huashen Zhiyao completed nearly 500million yuan of a-round financing and went deep into AI new drug development
Huamei Haolian, a health management service enterprise, completed round a+ financing, and Jinshajiang venture capital led the investment
Mojia biology announced the completion of round B financing
First class recall of Draeger, a ventilator giant
The state plans to prohibit third-party platforms from directly participating in online drug sales